Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs Delta Air Lines, Inc. (DAL) Price & Performance

ARK Genomic Revolution ETFTrade
Delta Air Lines, Inc.Trade

Price performance (Past 24H)

Key statistics

ARK Genomic Revolution ETF vs Delta Air Lines, Inc. — how do they compare? ARK Genomic Revolution ETF trades at $44.28, while Delta Air Lines, Inc. trades at $89.39 (market cap $59.46B). The key difference: Delta Air Lines, Inc. pays a 0.86% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.

ARKGDAL
Sector
Sector/ThematicIndustrials
52-Week High
$44.55$93.66
52-Week Low
$24.02$55.65
Market Cap
$59.46B
Enterprise Value
$74.77B
Dividend Yield
0.86%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Genomic Revolution ETF

No Aura AI signal available yet.

Delta Air Lines, Inc.

Delta Air Lines (DAL) trades at $89.21, down 2.33% on the day, amid strong fundamental performance with three consecutive quarterly earnings beats. The stock maintains attractive valuation metrics including a P/E of 14.99 and P/S of 0.87, while showing robust profitability with 20.12% ROE. Technical indicators suggest a bullish trend with current price near key support at $89. Recent corporate developments include dividend payments and strong cash flow generation of $1.08 billion in 2025.

DAL presents a compelling investment case with strong analyst support (82% buy ratings) and a $108.27 consensus price target implying 21% upside. The airline benefits from premium travel demand and lucrative loyalty partnerships, though faces headwinds from fuel cost volatility and competitive pressures. Earnings momentum remains positive with Q3 2026 expectations of $2.19 EPS.

Returns comparison

Trailing returns across standard periods

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About Delta Air Lines, Inc.

Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.

Read more on DAL